The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mueller, C. M.
Right arrow Articles by Scott, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, C. M.
Right arrow Articles by Scott, D. W.
The Journal of Immunology, 00, 165: 1854-1862.
Copyright © 00 by The American Association of Immunologists

Distinct Molecular Mechanisms of Fas Resistance in Murine B Lymphoma Cells1

Carolyn M. Mueller and David W. Scott2

Department of Immunology, J. H. Holland Laboratory for the Biomedical Sciences, American Red Cross, Rockville, MD 20855

A panel of murine B lymphoma cell lines, which express different levels of Fas, was extensively studied for sensitivity to Fas-mediated death signals via an anti-Fas mAb and Fas ligand-bearing cell lines. Expression of the Fas receptor on the B lymphoma cell lines did not correlate with their capacity to undergo Fas-mediated apoptosis. Moreover, Fas-associated death domain protein recruitment to the death-inducing signaling complex (DISC) complex occurred in all cell lines expressing Fas, regardless of whether they were sensitive to Fas-mediated death. Interestingly, the protein synthesis inhibitor, cycloheximide, and protein kinase C inhibitors, such as bisindolylmaleimide, rendered one of the resistant cell lines, CH33, sensitive to signals from the Fas receptor, although the levels of Fas were unchanged. This suggests that constitutive PKC activation plays a role in Fas resistance, perhaps by up-regulating NF-{kappa}B or Bcl-2 family members. Interestingly, CH33 demonstrated caspase 8 activity upon engagement of the Fas receptor in the absence of pharmacological manipulation, suggesting that the block in apoptosis is downstream of the DISC complex. In contrast, the fact that Fas-associated death domain protein was recruited to the DISC complex in other resistant lines, such as WEHI-231, with no caspase 8 activation indicates that these cells may be blocked within the DISC complex. Indeed, Western blot analysis showed that WEHI-231 expressed an isoform of FLICE-like inhibitory protein (cFLIPL), an antiapoptotic protein within the DISC. These studies provide evidence that murine B lymphoma cells utilize different molecular mechanisms along the Fas-signaling cascade to block apoptosis.




This article has been cited by other articles:


Home page
GENES CELLSHome page
T. Ishioka, R. Katayama, R. Kikuchi, M. Nishimoto, S. Takada, R. Takada, S.-i. Matsuzawa, J. C. Reed, T. Tsuruo, and M. Naito
Impairment of the ubiquitin-proteasome system by cellular FLIP
Genes Cells, June 1, 2007; 12(6): 735 - 744.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Naito, R. Katayama, T. Ishioka, A. Suga, K. Takubo, M. Nanjo, C. Hashimoto, M. Taira, S. Takada, R. Takada, et al.
Cellular FLIP Inhibits {beta}-Catenin Ubiquitylation and Enhances Wnt Signaling
Mol. Cell. Biol., October 1, 2004; 24(19): 8418 - 8427.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Qin, B. Camoretti-Mercado, L. Blokh, C. G. Long, F. D. Ko, and K. J. Hamann
Fas Resistance of Leukemic Eosinophils Is Due to Activation of NF-{kappa}B by Fas Ligation
J. Immunol., October 1, 2002; 169(7): 3536 - 3544.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. J. Page, S. O'Brien, C. R. Jefcoate, and C. J. Czuprynski
7,12-Dimethylbenz[a]anthracene Induces Apoptosis in Murine Pre-B Cells through a Caspase-8-Dependent Pathway
Mol. Pharmacol., August 1, 2002; 62(2): 313 - 319.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Poulaki, C. S. Mitsiades, V. Kotoula, S. Tseleni-Balafouta, A. Ashkenazi, D. A. Koutras, and N. Mitsiades
Regulation of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Thyroid Carcinoma Cells
Am. J. Pathol., August 1, 2002; 161(2): 643 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. H. Igney and P. H. Krammer
Immune escape of tumors: apoptosis resistance and tumor counterattack
J. Leukoc. Biol., June 1, 2002; 71(6): 907 - 920.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mitsiades, C. S. Mitsiades, V. Poulaki, K. C. Anderson, and S. P. Treon
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells
Blood, March 15, 2002; 99(6): 2162 - 2171.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Snow, L. J. Chen, R. R. Nepomuceno, S. M. Krams, C. O. Esquivel, and O. M. Martinez
Resistance to Fas-Mediated Apoptosis in EBV-Infected B Cell Lymphomas Is Due to Defects in the Proximal Fas Signaling Pathway
J. Immunol., November 1, 2001; 167(9): 5404 - 5411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Weisberg, E. Ashkenazi, Z. Israel, M. Attia, Y. Shoshan, F. Umansky, and C. Brodie
Anaplastic and Atypical Meningiomas Express High Levels of Fas and Undergo Apoptosis in Response to Fas Ligation
Am. J. Pathol., October 1, 2001; 159(4): 1193 - 1197.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
Y.-j. Lee and E. Shacter
Fas Aggregation Does Not Correlate with Fas-Mediated Apoptosis
J. Immunol., July 1, 2001; 167(1): 82 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gomez-Angelats and J. A. Cidlowski
Protein Kinase C Regulates FADD Recruitment and Death-inducing Signaling Complex Formation in Fas/CD95-induced Apoptosis
J. Biol. Chem., November 21, 2001; 276(48): 44944 - 44952.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.